221 related articles for article (PubMed ID: 28382542)
1. KK-92A, a novel GABA
Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A
Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542
[TBL] [Abstract][Full Text] [Related]
2. Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats.
Vlachou S; Guery S; Froestl W; Banerjee D; Benedict J; Finn MG; Markou A
Psychopharmacology (Berl); 2011 May; 215(1):117-28. PubMed ID: 21181127
[TBL] [Abstract][Full Text] [Related]
3. The Novel Positive Allosteric Modulator of the GABA
Maccioni P; Kaczanowska K; Lawrence H; Yun S; Bratzu J; Gessa GL; McDonald P; Colombo G
Front Cell Dev Biol; 2021; 9():727576. PubMed ID: 34778249
[TBL] [Abstract][Full Text] [Related]
4. Suppressing effect of CMPPE, a new positive allosteric modulator of the GABA
Maccioni P; Fara F; Lorrai I; Acciaro C; Mugnaini C; Corelli F; Colombo G
Alcohol; 2019 Mar; 75():79-87. PubMed ID: 30468987
[TBL] [Abstract][Full Text] [Related]
5. COR758, a negative allosteric modulator of GABA
Porcu A; Mostallino R; Serra V; Melis M; Sogos V; Beggiato S; Ferraro L; Manetti F; Gianibbi B; Bettler B; Corelli F; Mugnaini C; Castelli MP
Neuropharmacology; 2021 May; 189():108537. PubMed ID: 33798546
[TBL] [Abstract][Full Text] [Related]
6. Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats.
Paterson NE; Vlachou S; Guery S; Kaupmann K; Froestl W; Markou A
J Pharmacol Exp Ther; 2008 Jul; 326(1):306-14. PubMed ID: 18445779
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and side effects of baclofen and the novel GABA
Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
[TBL] [Abstract][Full Text] [Related]
8. Development of Partial Tolerance to the Suppressing Effect of the Positive Allosteric Modulator of the GABAB Receptor, KK-92A, on Alcohol Self-Administration in Rats.
Maccioni P; Kaczanowska K; McDonald P; Colombo G
Alcohol Alcohol; 2022 Nov; 57(6):706-711. PubMed ID: 35589119
[TBL] [Abstract][Full Text] [Related]
9. GABA
de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER
Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860
[TBL] [Abstract][Full Text] [Related]
10. GABA
Sturchler E; Li X; de Lourdes Ladino M; Kaczanowska K; Cameron M; Griffin PR; Finn MG; Markou A; McDonald P
Pharmacol Res Perspect; 2017 Apr; 5(2):e00288. PubMed ID: 28357120
[TBL] [Abstract][Full Text] [Related]
11. The GABA
Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats.
Maccioni P; Zaru A; Loi B; Lobina C; Carai MA; Gessa GL; Capra A; Mugnaini C; Pasquini S; Corelli F; Hyytiä P; Lumeng L; Colombo G
Alcohol Clin Exp Res; 2012 Oct; 36(10):1748-66. PubMed ID: 22486245
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.
Li X; D'Souza MS; Niño AM; Doherty J; Cross A; Markou A
Psychopharmacology (Berl); 2016 May; 233(10):1801-14. PubMed ID: 26873083
[TBL] [Abstract][Full Text] [Related]
14. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
[TBL] [Abstract][Full Text] [Related]
15. Delving into the reducing effects of the GABA
Maccioni P; Kaczanowska K; Lobina C; Regonini Somenzi L; Bassareo V; Gessa GL; Lawrence HR; McDonald P; Colombo G
Alcohol; 2023 Nov; 112():61-70. PubMed ID: 37495087
[TBL] [Abstract][Full Text] [Related]
16. Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABA(B) receptor, BHF177, in alcohol-preferring rats.
Maccioni P; Carai MA; Kaupmann K; Guery S; Froestl W; Leite-Morris KA; Gessa GL; Colombo G
Alcohol Clin Exp Res; 2009 Oct; 33(10):1749-56. PubMed ID: 19572981
[TBL] [Abstract][Full Text] [Related]
17. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses.
Filip M; Frankowska M
Eur J Pharmacol; 2007 Oct; 571(2-3):166-73. PubMed ID: 17610868
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of GABAB receptor subtypes assembled with auxiliary KCTD subunits.
Rajalu M; Fritzius T; Adelfinger L; Jacquier V; Besseyrias V; Gassmann M; Bettler B
Neuropharmacology; 2015 Jan; 88():145-54. PubMed ID: 25196734
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulators of the GABAB receptor: a new class of ligands with therapeutic potential for alcohol use disorder.
Colombo G
Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38566580
[TBL] [Abstract][Full Text] [Related]
20. Potential of GABA
Maccioni P; Colombo G
CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
